This analysis for the KFF-Peterson Well being System Tracker compares the Medicare’s first-ever negotiated drug costs beneath a brand new course of created by the Inflation Discount Act of 2022 to present U.S. checklist costs, costs negotiated by the Division of Veterans Affairs (VA), and costs in 11 nations of comparable measurement and wealth.
It finds that Medicare’s negotiated costs for 10 high-expenditure pharmaceuticals are decrease than what personal Medicare drug plans had been paying, however nonetheless a lot larger than the costs out there in different nations – 78% extra on common than the nation with the following highest worth throughout 11 different rich nations.
The evaluation is accessible on the Peterson-KFF Health System Tracker, a web based info hub devoted to monitoring and assessing the efficiency of the U.S. well being system.
